GI Partners Completes Acquisition of Charles River’s CDMO and Cell Solutions Businesses, Launches Rose BioSolutions

Creates Standalone Leader in Advanced Therapy Manufacturing with Decades of Proven Experience and Continued Commitment to Client Service Dedicated Resou...

May 11, 2026 | Monday | News
WuXi Biologics Secures South Korea MFDS GMP Certification for Three Wuxi Facilities

 WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manu...

April 24, 2026 | Friday | News
Crown Bioscience Partners with Turbine to Advance Translational Oncology with Integrated In Silico and Organoid Platforms

 Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, announced a strategic partnership with Turbine, a ...

April 23, 2026 | Thursday | News
Making Nucleic Acid Therapeutics Manufacturing More Sustainable at Scale

The demand for nucleic acid therapeutics (NATs) is rapidly altering the therapeutic landscape across a wide range of diseases. Recent industry data highlig...

April 20, 2026 | Monday | Expert Opinion
IDT Launches Next-Generation Sequencing Innovations To Streamline Cancer Genomics Workflows

New innovations designed to simplify NGS workflows Enhances critical variant identification through improved technologies Roadmap advances provide flex...

February 25, 2026 | Wednesday | News
Worldwide Clinical Trials Completes Catalyst Clinical Research Acquisition to Expand Oncology and Global CRO Capabilities

CRO expands oncology, adds functional service provider capabilities, strengthens global reach, and accelerates technology to enhance customer value ...

February 18, 2026 | Wednesday | News
Longeveron Secures FDA Type C Meeting Ahead of Pivotal ELPIS II Data Readout in HLHS

ELPIS II top-line trial results are anticipated in the third quarter of 2026 Laromestrocel Biological License Application (BLA) submission for full tr...

January 28, 2026 | Wednesday | News
Johnson & Johnson: CAPLYTA® Nearly Doubles Remission Rates at Six Weeks as Adjunctive Therapy in Major Depressive Disorder

CAPLYTA® nearly doubled the likelihood of remission at six weeks compared to placebo as an adjunctive therapy to an antidepressant based on pooled da...

January 19, 2026 | Monday | News
Insilico Medicine and Servier Enter AI-Driven Oncology R&D Collaboration Valued at Up to US$888 Million

Insilico Medicine achieved an R&D collaboration with Servier valued at up to US$888 million, focused on discovering and de...

January 06, 2026 | Tuesday | News
Hope Biosciences Reports Phase II Breakthrough Showing Significant Motor Improvement in Parkinson’s Disease

Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF)  shares positive top-line results of a Phase II clinical tri...

December 24, 2025 | Wednesday | News
Symeres Secures SBTi Approval for Science-Based Emissions Reduction Targets

Symeres, a leading contract research, development, and manufacturing organisation (CRDMO), has received its first approval from the Science Based Targets i...

December 19, 2025 | Friday | News
VNA-318 Demonstrates Strong Target Engagement and Safety in First-in-Human Trial

VNA-318, an oral brain-penetrant small molecule therapeutic modulates a novel target to reduce inflammation and improve mitochondrial function First-i...

December 03, 2025 | Wednesday | News
Dupixent Delivers First Positive Phase 3 Results in Allergic Fungal Rhinosinusitis

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal cong...

November 10, 2025 | Monday | News
Abzena and Mabqi Announce Strategic Partnership to Deliver End-to-End Antibody Discovery and Development

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on the discovery and d...

November 07, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close